Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in
Closed
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverDGX
HealthcareNYQUSD

Quest Diagnostics Incorporated

$001234567890012345678900123456789.0012345678900123456789-0.8%
52w low $171.18$248.84 52w high
Market data · updated 7h ago
Market data
Market cap
$25.60B
52w range
$171.18 - $248.84
Beta
0.55
Sector
Healthcare
Data quality
100/100
Valuation
P/E ratio
24.6x
fair value estimate
$292.02
Margin of safety
+26.4%
Forward P/E
19.2x
PEG ratio
1.51
Dividend yield
1.48%
Quality & efficiency
Moat score
52/100
Return on equity
14.6%
Profit margin
9.2%
Debt / equity
0.81
Growth & analysts
Revenue growth
+10.2%
Analyst target
$247.73
Target upside
+7.2%
Analysts
15
Run the 10-point checklist before you buy How these numbers are made

About Quest Diagnostics Incorporated

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Valuation

ValueGrowthProfitHealthIncome51QUALITY
Overall Rating
67
Good quality
Good quality

Derived from filed metrics · High confidence (100% of the inputs available)

Moat Score52
Fair value estimate
$292.02+26.4% upside

Moat, fair value and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
$25.60B
P/E Ratio
24.6
Dividend Yield
1.48%
Revenue Growth
+10.2%
Profit Margin
9.2%
ROE
14.6%
Debt / Equity
0.81
Beta
0.55

Statistics

Similar Stocks · Healthcare

Latest News · DGX